Livetency 200mg Tablets: New Hope for CMV Patients or Just Another Risky Drug?
Livtencity 200mg Tablets have recently been approved for treating cytomegalovirus (CMV) in transplant recipients who don't respond to or can't tolerate other medications. While this offers a new hope for those with limited options, it also comes with a list of severe potential side effects. This thread is aimed at discussing the efficacy, side effects, and personal experiences with Livtencity. Let's hear from those who have used it, healthcare professionals, and anyone else with insights on this new treatment option.
medicine
transplant
CMV
teresa_henry · 2d ago1 min read
last active 2d ago
HOT